Niadn

Raja, R., Thomas, J.M., Greenhill-Hooper, M., Ley, S.V., and Almeida Paz, F.A. (2008) Fadle, one-step production of niadn (Vitamin B3) and other nittogen-containing pharmaceutical chemicals with a single-site heterogeneous catalyst. Chem. Eur. J., 14, 2430-2438. 

Neosporin Maximum Strength 78 Neosporin Plus 78 Neosynephrine 56 Neupogen 35 Neuromin 38 Neutraphos 56 Nevirapine 51 Niadn 51... 

I Brand Name(s) Niacor, Niaspan ER, Nicotinex, Slo-Niadn... 

Niaspan) Extended-release niacin -i- tablets Niadn/lovastatin SOO-msyzo- 500 m y20 mg 1,000 mg/... 

There is some interest in using the ratio of NAD/NADF in red blood cells as a convenient measure of niadn status (Jacobson and Jacobson, 1997). How could this assay work Data from human studies has shown that niadn deficiency allows a decline in intracellular NAD, but a maintenance of the levels of NADP. 

B. The ring portion of tryptophan may be converted to the nicotinamide moiety of NAD, which may also be derived from the vitamin niadn. 

Jacob RA. Niadn. In Bowman BA, Russell RM, eds. Present knowledge in nutrition. Washington, DC ... 

Niacinamide hydroiodide + potassium iodide (e.g., lodo-Niadn) Ponaris nasal emollient Potassium iodide (e.g., Quadrinal)... 

P7. Price, J. M., Brown, R. R., and Yess, N., Testing the functional capacity of the tryptophan-niadn pathway in man by analysis of urinary metabolites. Advan. Metab. Disord. 2, 159-225 (1965). 

Simultaneous diazepam, diphenhydramine, o-hydroxyhippvuuc add, MPPH, niadn, toluene... 

Nicotinic acid (niacin) and Nicotinamide (niadn-amide) (pellagra preventative factor V.PP) are metabolically interconvertible, water-soluble, simple pyridine derivatives with equal V. activity. They are widely distributed in nature, and are especially plen-... 

Niadn Meat, whole grains, poultry, fish Forms the coenzyme NAD, which is a hydride transporter Pellagra weak muscles, no appetite, diarrhea, dermatitis... 

Salvage Pathway from Niadn. In humans, nicotinic acid is converted to nicotinic acid mononucleotide by the catalytic action of nicotin phosphorybosyltransferase-1. By the action of NMNAT(s) and NAD syn-thase-1, this compound is then transformed to NAD (Figure 7.2). 

The absorption of niacin in the human body mainly occurs in the stomach and small intestine (Bechgaard and Jespersen 1977). Niacin is taken up by the body swiftly and quickly, and reaches peak plasma levels within 30-60 minutes of being absorbed (Bodor and Offermanns 2008). Furthermore it has a plasma half-life of 60 minutes (Carlson et al. 1968 Svedmyr and Harthon 1970). The enzyme nicotinamide adenine dinucleotide (NAD) glycohydrolase, which is found in the intestine and liver, faciUtates the synthesis of nicotinamide from NAD (Henderson and Gross 1979). This is an important step that ensures the availability of nicotinamide for the conversion to NAD. Niacin is metabolized in most tissues in the body and its metaboKtes are excreted in urine (Jacob et al. 1989 Shibata and Matsuo 1989). Importantly, niadn deficiency occurs mainly as a result of poor diet, but also other conditions such as carcinoid syndrome, Hartnup s disease and drug intake (isoniazid) (Hegyi et al. 2004). 

Niacin deficiency leads to unwanted multisystemic problems that are often associated with dermatological changes. Pellagra is a condition in which niacin deficiency causes a symmetrical pigmented rash, thickened skin and superficial scaling which are found in sun-exposed body areas. The classic triad of niacin deficiency are the three D s—dermatitis, diarrhoea and dementia (Hegyi et al. 2004). Some of the effects on the central nervous system include depression, anxiety, restlessness and poor concentration. In addition, alcoholic individuals with poor nutrition can develop pellagroid encephalopathy (Cook et al. 1998). The role of niadn deficiency in cardiovascular disease and lipid metabolism remains to be fully explored. 

In addition to its eflect on SR-Bl, niacin can also stimulate ABCA-1 mediated cholesterol efflux from macrophages, which will contribute to niadn-mediated increases in HDL-C (Morgan et al. 2007 Rubic et al. 2004). Niacin also increases the ability of HDL to take up additional cholesterol from peripheral cells and tissues, as well as its ability to mediate cholesterol transport via SB-Bl, via inhibition of hepatic uptake of small HDL by endocytosis—in effect recycling HDL (Morgan et al. 2007). Thus niacin has been shown to promote cellular cholesterol release via more than one mechanism. 

Etchason, J.A., Miller, T.D., Squires, R.W., Alhson, T.G., Gau, G.T., Mart-tila, J.K., and Kottke, B.A., 1991. Niadn-induced hepatitis a potential side effect with low-dose time-release niacin. Mayo Clinic Proceedings. 66 23-28. 

Knopp, R.H., Retzlaff, B.M., Fish, B., Dowdy, A., Twaddell, B., Nguyen, T., and Paramsothy, P., 2009. Slo-Niadn and atorvastatin treatment of lipoproteins and inflammatory markers in combined hyperlipidemia. Journal of... 

Perricone, N.V., Bagchi, D., Echard, B., and Preuss, H.G., 2010. Long-term metabolic effects of different doses of niadn-bound chromium on Sprague-Dawley rats. Molecular and Cellular Biochemistry. 338 91-103. 

---